Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on the research, cultivation, manufacturing, and sale of breakthrough cannabis-based medicines, announces that further to the 6 June 2025 announcement, it
Celadon Pharmaceuticals Plc (AIM: CEL), a UK-based pharmaceutical company focused on the research, cultivation, manufacturing, and sale of breakthrough cannabis-based medicines, announces that further to the 6 June 2025 announcement, it
London shares held steady after official data revealed a 1% rise in retail sales volumes for February, marking the highest level since July 2022. UK shares were muted at the
The FTSE 100 climbed 0.6%, closing at 8,809.74, just 11 points shy of its all-time high earlier this month.
Shares in Celadon Pharmaceuticals PLC (AIM: CEL), a UK-based pharmaceutical company specialising in cannabis-based medicines, surged over 25% in early trading following a financial update.
Celadon Pharmaceuticals PLC (AIM: CEL) saw its value more than double following a supply agreement that will help it fulfil a German medical cannabis contract signed over a year ago.
The FTSE 100 dropped by 0.5% as investors responded to news of British insurer Aviva’s £3.6 billion acquisition of Direct Line. Retailer B&M led the index with a 2.7% gain,
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Capital Metals,
Footsie Ends the Week on a High as Global Markets Rally. The FTSE 100 closed higher, buoyed by positive global market sentiment following comments from Jerome Powell. The Federal Reserve
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s charts are FTSE 100, Dax, Dow, Bitcoin, Gold, Celadon Pharmaceuticals,
Shares in Celadon Pharmaceuticals PLC (AIM: CEL) plummeted 50% in early trading due to delays in accessing £1.3 million of funding.